Author Bauer, S.

• 2002 | Conference Abstract
  ​ ​Influence of CYP2C9 genotype on pharmacokinetics of tolbutamide and glibenclamide.​
  Roots, I.; Kirchheiner, J.; Bauer, S. & Brockmoeller, J.​ (2002)
  Clinical Pharmacology & Therapeutics, 71(2) 
  St louis​: Mosby, Inc.
  ​Details  WoS 

• 2002 | Journal Article
  ​ ​Impact of CYP2C9 amino acid polymorphisms on glyburide kinetics and on the insulin and glucose response in healthy volunteers​
  Kirchheiner, J.; Brockmoeller, J.; Meineke, I.; Bauer, S.; Rohde, W.; Meisel, C. & Roots, I.​ (2002) 
  Clinical Pharmacology & Therapeutics, 71(4) pp. 286​-296​.​ DOI: https://doi.org/10.1067/mcp.2002.122476 
  ​Details  DOI  PMID  PMC  WoS 

• 2002 | Journal Article
  ​ ​Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: Insights into the measurement of hepatic cytochrome P450 1A2 induction​
  Abraham, K.; Geusau, A.; Tosun, Y.; Helge, H.; Bauer, S. & Brockmoeller, J.​ (2002) 
  Clinical Pharmacology & Therapeutics, 72(2) pp. 163​-174​.​ DOI: https://doi.org/10.1067/mcp.2002.126408 
  ​Details  DOI  PMID  PMC  WoS 

• 2002 | Journal Article
  ​ ​Impact of CYP2C9 and CYP2C19 polymorphisms on tolbutamide kinetics and the insulin and glucose response in healthy volunteers​
  Kirchheiner, J.; Bauer, S.; Meineke, I.; Rohde, W.; Prang, V.; Meisel, C. & Roots, I. et al.​ (2002) 
  PHARMACOGENETICS, 12(2) pp. 101​-109​.​ DOI: https://doi.org/10.1097/00008571-200203000-00004 
  ​Details  DOI  PMID  PMC  WoS 

• 2002 | Journal Article
  ​ ​Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6 beta-hydroxycortisol in healthy volunteers​
  Bauer, S.; Stormer, E.; Kerb, R.; Johne, A.; Brockmoeller, J. & Roots, I.​ (2002) 
  European Journal of Clinical Pharmacology, 58(9) pp. 581​-585​.​ DOI: https://doi.org/10.1007/s00228-002-0527-5 
  ​Details  DOI  PMID  PMC  WoS 

• 2002 | Journal Article
  ​ ​Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes​
  Kaiser, R.; Sezer, O.; Papies, A.; Bauer, S.; Schelenz, C.; Tremblay, P. B. & Possinger, K. et al.​ (2002) 
  Journal of Clinical Oncology, 20(12) pp. 2805​-2811​.​ DOI: https://doi.org/10.1200/JCO.2002.09.064 
  ​Details  DOI  PMID  PMC  WoS 

• 2003 | Journal Article
  ​ ​Modeling of karst aquifer genesis: Influence of exchange flow​
  Bauer, S.; Liedl, R. & Sauter, M.​ (2003) 
  Water Resources Research, 39(10) art. 1285​.​ DOI: https://doi.org/10.1029/2003WR002218 
  ​Details  DOI  WoS 

• 2003 | Journal Article
  ​ ​Rapid and simple method for the analysis of nateglinide in human plasma using HPLC analysis with UV detection​
  Bauer, S.; Stormer, E.; Kirchheiner, J.; Michael, C.; Brockmoeller, J. & Roots, I.​ (2003) 
  Journal of Pharmaceutical and Biomedical Analysis, 31(3) pp. 551​-555​.​ DOI: https://doi.org/10.1016/S0731-7085(02)00680-5 
  ​Details  DOI  PMID  PMC  WoS 

• 2003 | Journal Article
  ​ ​Cytochrome P450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: Correlation with alprazolam pharmacokinetics​
  Gashaw, I.; Kirchheiner, J.; Goldammer, M.; Bauer, S.; Seidemann, J.; Zoller, K. & Mrozikiewicz, P. M. et al.​ (2003) 
  Clinical Pharmacology & Therapeutics, 74(5) pp. 448​-457​.​ DOI: https://doi.org/10.1016/S0009-9236(03)00237-6 
  ​Details  DOI  PMID  PMC  WoS 

• 2003 | Journal Article
  ​ ​Influence of CYP2C9 polymorphisms on the pharmacokinetics and cholesterol-lowering activity of (-)-3S,5R-fluvastatin and (+)-3R,5S-fluvastatin in healthy volunteers​
  Kirchheiner, J.; Kudlicz, D.; Meisel, C.; Bauer, S.; Meineke, I.; Roots, I. & Brockmoeller, J.​ (2003) 
  Clinical Pharmacology & Therapeutics, 74(2) pp. 186​-194​.​ DOI: https://doi.org/10.1016/S0009-9236(03)00121-8 
  ​Details  DOI  PMID  PMC  WoS 

Researcher

Sort

Items per Page